Literature DB >> 31704094

Epidemiology of diabetes phenotypes and prevalent cardiovascular risk factors and diabetes complications in the National Health and Nutrition Examination Survey 2003-2014.

Michael P Bancks1, Ramon Casanova2, Edward W Gregg3, Alain G Bertoni4.   

Abstract

AIMS: To characterize unique diabetes phenotypes among National Health and Nutrition Examination Survey (NHANES) participants and assess associations with race/ethnicity, cardiovascular disease (CVD) risk factors, and prevalent complications.
METHODS: We included participants (age ≥ 20 years) from NHANES exams 2003-04 through 2013-14 with diabetes (self-report of diabetes diagnosis or medication use, fasting glucose ≥7.0 mmol/L, random glucose ≥11.1 mmol/L, and glycated hemoglobin (HbA1c) ≥ 48 mmol/mol). We used k-means clustering to characterize unique diabetes subgroups based on data for age of diabetes diagnosis, body mass index (BMI), waist circumference, HbA1c, and years of insulin use. We estimated subgroup prevalence of CVD risk factors and microvascular complications, accounting for demographics and survey sampling.
RESULTS: Among 4300 adults with diabetes, we identified four unique subgroups of diabetes related to aging (AR, 51.3%), severe obesity (SO, 30.3%), severe hyperglycemia (SH, 12.5%), and young adulthood-onset (YA, 5.9%). We observed differences in subgroup proportion by race/ethnicity. Compared to the AR phenotype, all groups had higher HbA1c and BMI, the YA and SO groups had greater blood pressure, and the YA group had greater prevalence of renal, eye, and neuropathy complications.
CONCLUSIONS: Whether consideration of diabetes phenotypes with treatment strategies reduce diabetes incidence, morbidity, and mortality merits evaluation.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31704094     DOI: 10.1016/j.diabres.2019.107915

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  10 in total

1.  Where Do We Stand with Closed-Loop Systems and Their Challenges?

Authors:  Melanie Jackson; Jessica R Castle
Journal:  Diabetes Technol Ther       Date:  2020-05-22       Impact factor: 6.118

2.  Association of Diabetes Subgroups With Race/Ethnicity, Risk Factor Burden and Complications: The MASALA and MESA Studies.

Authors:  Michael P Bancks; Alain G Bertoni; Mercedes Carnethon; Haiying Chen; Mary Frances Cotch; Unjali P Gujral; David Herrington; Alka M Kanaya; Moyses Szklo; Dhananjay Vaidya; Namratha R Kandula
Journal:  J Clin Endocrinol Metab       Date:  2021-04-23       Impact factor: 5.958

3.  Type 2 Diabetes Subgroups, Risk for Complications, and Differential Effects Due to an Intensive Lifestyle Intervention.

Authors:  Michael P Bancks; Haiying Chen; Ashok Balasubramanyam; Alain G Bertoni; Mark A Espeland; Steven E Kahn; Scott Pilla; Elizabeth Vaughan; Lynne E Wagenknecht
Journal:  Diabetes Care       Date:  2021-03-11       Impact factor: 19.112

4.  Diabetes subgroups and risk for complications: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Michael P Bancks; Mercedes Carnethon; Haiying Chen; Mary Frances Cotch; Barbara Klein; Ronald Klein; Moyses Szklo; Alain Bertoni
Journal:  J Diabetes Complications       Date:  2021-03-26       Impact factor: 3.219

5.  Stroke Risk Factors in United States: An Analysis of the 2013-2018 National Health and Nutrition Examination Survey.

Authors:  Zhouming Ren; Xinzheng Fu
Journal:  Int J Gen Med       Date:  2021-09-28

6.  Hydration Status and Fluid Replacement Strategies of High-Performance Adolescent Athletes: An Application of Machine Learning to Distinguish Hydration Characteristics.

Authors:  Haresh T Suppiah; Ee Ling Ng; Jericho Wee; Bernadette Cherianne Taim; Minh Huynh; Paul B Gastin; Michael Chia; Chee Yong Low; Jason K W Lee
Journal:  Nutrients       Date:  2021-11-15       Impact factor: 5.717

7.  Validation of type 2 diabetes subgroups by simple clinical parameters: a retrospective cohort study of NHANES data from 1999 to 2014.

Authors:  Jing Xie; Hua Shao; Tao Shan; Shenqi Jing; Yaxiang Shi; Junjie Wang; Jie Hu; Yong Li; Ruochen Huang; Naifeng Liu; Yun Liu
Journal:  BMJ Open       Date:  2022-03-30       Impact factor: 2.692

8.  Clinical characterization of data-driven diabetes subgroups in Mexicans using a reproducible machine learning approach.

Authors:  Omar Yaxmehen Bello-Chavolla; Jessica Paola Bahena-López; Arsenio Vargas-Vázquez; Neftali Eduardo Antonio-Villa; Alejandro Márquez-Salinas; Carlos A Fermín-Martínez; Rosalba Rojas; Roopa Mehta; Ivette Cruz-Bautista; Sergio Hernández-Jiménez; Ana Cristina García-Ulloa; Paloma Almeda-Valdes; Carlos Alberto Aguilar-Salinas
Journal:  BMJ Open Diabetes Res Care       Date:  2020-07

9.  Precision Medicine in Type 2 Diabetes: Using Individualized Prediction Models to Optimize Selection of Treatment.

Authors:  John M Dennis
Journal:  Diabetes       Date:  2020-08-25       Impact factor: 9.461

10.  Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study.

Authors:  Roderick C Slieker; Louise A Donnelly; Hugo Fitipaldi; Gerard A Bouland; Giuseppe N Giordano; Mikael Åkerlund; Mathias J Gerl; Emma Ahlqvist; Ashfaq Ali; Iulian Dragan; Andreas Festa; Michael K Hansen; Dina Mansour Aly; Min Kim; Dmitry Kuznetsov; Florence Mehl; Christian Klose; Kai Simons; Imre Pavo; Timothy J Pullen; Tommi Suvitaival; Asger Wretlind; Peter Rossing; Valeriya Lyssenko; Cristina Legido-Quigley; Leif Groop; Bernard Thorens; Paul W Franks; Mark Ibberson; Guy A Rutter; Joline W J Beulens; Leen M 't Hart; Ewan R Pearson
Journal:  Diabetologia       Date:  2021-06-10       Impact factor: 10.122

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.